@kmakm, too right, it is part of the work that was discussed by Jason Carroll :) Exciting developments in a few different areas that hopefully won't be too long in coming to pass. The Garvan session was so informative and gives me hope that real progress is not too far into the future.
@arpie, from what I understand, they would look at the genetic makeup of the tumour rather than tumour size, aggressiveness, age of the patient and tumour type only to make a more accurate prediction. Getting that genetic testing done though probably opens a huge can of worms in terms of costs etc but would actually save the health system a ton of money in the long term.